Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess
Author:
Funder
FONDECYT POSTDOCTORAL
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-022-03103-x.pdf
Reference61 articles.
1. J.W. Funder, Apparent mineralocorticoid excess. J. Steroid Biochem Mol. Biol. 165(Pt A), 151–153 (2017)
2. K. Kosicka, M. Cymerys, A. Majchrzak-Celinska, M. Chuchracki, F.K. Glowka, 11beta-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis. J. Hum. Hypertens. 27(8), 510–515 (2013)
3. J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889–1916 (2016)
4. C.A. Carvajal, A. Tapia-Castillo, A. Vecchiola, R. Baudrand, C.E. Fardella, Classic and nonclassic apparent mineralocorticoid excess syndrome. J. Clin. Endocrinol. Metab. 105, 4 (2020)
5. A. Vaidya, P. Mulatero, R. Baudrand, G.K. Adler, The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr. Rev. 39(6), 1057–1088 (2018)
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Letter to the Editor From Tapia-Castillo et al.: “Considerations About the Indirect Role of Low Cortisone in Subjects With Normal Cortisol to Cortisone Ratio”;Journal of the Endocrine Society;2024-07-26
2. Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism;Frontiers in Endocrinology;2023-05-08
3. Urinary extracellular vesicles carry valuable hints through mRNA for the understanding of endocrine hypertension;Frontiers in Endocrinology;2023-03-29
4. Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension;Frontiers in Endocrinology;2022-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3